Vietnamese Minister of Foreign Affairs Bui Thanh Son met with Speaker of the National Assembly of the Republic of Korea (RoK) Park Byeong-seug and the RoK’s Deputy Prime Minister and Minister of Economy and Finance Hong Nam-ki in Seoul on February 11.

The National Assembly (NA) Standing Committee on December 30, 2021 issued a resolution allowing the implementation of a number of mechanisms and policies in the healthcare sector serving COVID-19 prevention and control activities, including the management of drug and drug ingredients.

VOV.VN - The Medicine Patent Pool (MPP) on January 20 announced it has granted licenses to manufacture the COVID-19 treatment drug Molnupiravir to 27 pharmaceutical firms worldwide, including Stella Vietnam (Stellapharm).

VOV.VN - Vietnam expects drug maker AstraZeneca will continue to provide new generation COVID-19 vaccines and drugs to Vietnam to increase its protection capacity against new strains.

VOV.VN - A number of antiviral drugs specifically for COVID-19 treatment such as Molnupiravir and Favipiravir are being traded on the black market locally at various prices and with unreliable quality, though they are strictly prescribed by doctors.

VOV.VN - The border guard force have broken a large drug tracking ring in the north-western province of Dien Bien, arresting three suspects along with 144,000 pills of synthetic drugs and 12 cakes of heroin.

Deputy Health Minister Truong Quoc Cuong and 13 others are facing charges for their role in counterfeit cancer medicines labelled as Health 2000 Canada, according the new indictment issued by the Supreme People’s Procuracy.

VOV.VN - The Drug Administration of Vietnam under the Ministry of Health (MoH) has issued a document to tighten inspections, examinations, and handling of violations in COVID-19 drug trading.

Vietnam, Cambodia and Laos have committed to enhancing cooperation in fighting transnational crimes in all forms, especially drug crime, human trafficking, smuggling, terrorism and high-tech crime.

VOV.VN - Health professionals of the Ministry of Health are due to meet on January 5 to consider licensing local pharmaceutical companies that produce Molnupiravir for COVID-19 treatment.